Live Verdure Ltd - Asset Resilience Ratio
Live Verdure Ltd (LV1) has an Asset Resilience Ratio of 0.03% as of June 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See LV1 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2022)
This chart shows how Live Verdure Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Live Verdure Ltd asset portfolio.
Liquid Assets Composition Over Time
This chart breaks down Live Verdure Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore LV1 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$1.10K | 0.03% |
| Total Liquid Assets | AU$1.10K | 0.03% |
Asset Resilience Insights
- Limited Liquidity: Live Verdure Ltd maintains only 0.03% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Live Verdure Ltd Industry Peers by Asset Resilience Ratio
Compare Live Verdure Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Galderma Group N
SW:GALD |
Drug Manufacturers - Specialty & Generic | 3.56% |
|
IPSEN SA SP.ADR 1/4/ EO 1
F:I7G0 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Harbin Gloria Pharmaceuticals
SHE:002437 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Teyi Pharmaceutical Group Co Ltd
SHE:002728 |
Drug Manufacturers - Specialty & Generic | 9.66% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
Annual Asset Resilience Ratio for Live Verdure Ltd (2020–2022)
The table below shows the annual Asset Resilience Ratio data for Live Verdure Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 0.17% | AU$4.18K ≈ $2.96K |
AU$2.49 Million ≈ $1.76 Million |
+0.08pp |
| 2021-12-31 | 0.09% | AU$1.10K ≈ $778.32 |
AU$1.29 Million ≈ $909.75K |
+0.06pp |
| 2020-12-31 | 0.03% | AU$1.10K ≈ $778.32 |
AU$4.17 Million ≈ $2.95 Million |
-- |
About Live Verdure Ltd
Decidr AI Industries Ltd operates as an agentic AI-enablement company. It offers AI-driven automation for marketing, administration, finance, project management, and more. The company was formerly known as Live Verdure Limited and changed its name to Decidr AI Industries Ltd in March 2025. Decidr AI Industries Ltd was incorporated in 2016 and is based in Sydney, Australia.